Suchergebnisse - "O'Day, Steven J"

PubPharm (9)

1

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

enthalten in: The New England journal of medicine | 2011

von Chapman, P. | Hauschild, A. | Robert, C. | +126

CommentIn: N Engl J Med. 2011 Jun 30;364(26):2547-8. - PMID 21639809

2

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

enthalten in: Investigational new drugs | 2011

von Hersh, E. | O'Day, S. | Powderly, J. | +7

3

Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von O'Day, S. | Atkins, M. | Boasberg, P. | +8

4

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2006

von Lewis, K. | Robinson, W. | McCarter, M. | +10

5

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2005

von Mori, T. | O'Day, S. | Umetani, N. | +10

6

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma : outcome prediction in a multicenter trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2005

von Koyanagi, K. | O'Day, S. | Gonzalez, R. | +8

7

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy : an exploratory study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2005

von Liu, D. | O'Day, S. | Yang, D. | +5

8

Biochemotherapy for metastatic melanoma with limited central nervous system involvement

enthalten in: Oncology | 2003

von Boasberg, P. | O'Day, S. | Kristedja, T. | +7

9

Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2002

von O'Day, S. | Boasberg, P. | Piro, L. | +9

1
[1]